Diabetes mellitus promotes susceptibility to periodontitis—novel insight into the molecular mechanisms

M Zhao, Y Xie, W Gao, C Li, Q Ye, Y Li - Frontiers in endocrinology, 2023 - frontiersin.org
Diabetes mellitus is a main risk factor for periodontitis, but until now, the underlying
molecular mechanisms remain unclear. Diabetes can increase the pathogenicity of the …

Pathogenesis and treatment of wound healing in patients with diabetes after tooth extraction

S Yang, Y Li, C Liu, Y Wu, Z Wan… - Frontiers in Endocrinology, 2022 - frontiersin.org
Diabetes mellitus is a common systematic chronic disease amongst dental patients. The
elevated glucose microenvironment can prolong the healing of tooth extraction sockets …

Curcumin Prevents Diabetic Osteoporosis through Promoting Osteogenesis and Angiogenesis Coupling via NF‐κB Signaling

D Fan, J Lu, N Yu, Y Xie, L Zhen - … ‐Based Complementary and …, 2022 - Wiley Online Library
Diabetic osteoporosis (DOP) is a metabolic disease which is characterized by impaired
bone microarchitecture and reduced bone mineral density resulting from hyperglycemia …

Protective effects of curcumin against osteoporosis and its molecular mechanisms: a recent review in preclinical trials

S Yang, Y Sun, L Kapilevich, X Zhang… - Frontiers in …, 2023 - frontiersin.org
Osteoporosis (OP) is one of the most common metabolic skeletal disorders and is commonly
seen in the elderly population and postmenopausal women. It is mainly associated with …

HO-1 in bone biology: potential therapeutic strategies for osteoporosis

X Zhou, W Yuan, X Xiong, Z Zhang, J Liu… - Frontiers in Cell and …, 2021 - frontiersin.org
Osteoporosis is a prevalent bone disorder characterized by bone mass reduction and
deterioration of bone microarchitecture leading to bone fragility and fracture risk. In recent …

[HTML][HTML] Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2 …

D Ke, H Xu, J Han, H Dai, X Wang, J Luo, Y Yu, J Xu - Biomedical journal, 2024 - Elsevier
Background Curcumin ameliorates bone loss by inhibiting osteoclastogenesis. Curcumin
inhibits RANKL-promoted autophagy in osteoclast precursors (OCPs), which mediates its …

A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization

J Deng, LM Golub, HM Lee, HD Bhatt, F Johnson… - Scientific Reports, 2023 - nature.com
To assess resolving-like activity by a novel chemically-modified curcumin (CMC2. 24) in a
“two-hit” model of diabetes-associated periodontitis. Macrophages from rats were cultured in …

[HTML][HTML] Jaw osteoporosis: Challenges to oral health and emerging perspectives of treatment

F Liu, X Wang, Y He, R Han, T Wang, Y Guo - Biomedicine & …, 2024 - Elsevier
Osteoporosis is a prevalent bone metabolic disease that poses a significant challenge to
global human health. Jaw osteoporosis, characterized by microstructural damage of the jaw …

Arrestin beta‐2 deficiency exacerbates periodontal inflammation by mediating activating transcription factor 6 activation and abnormal remodelling of the extracellular …

M Feng, R Wang, L Deng, Y Yang, S Xia… - Journal of Clinical …, 2024 - Wiley Online Library
Aim To investigate the specific role of arrestin beta‐2 (ARRB2) in the progression of
periodontitis and the underlying mechanisms. Materials and Methods Single‐cell RNA …

Novel hydrogenated derivatives of chemically modified curcumin cmc2. 24 are potent inhibitors of melanogenesis in an in vitro model: influence of degree of …

S Goenka - Life, 2023 - mdpi.com
Chemically modified curcumin, CMC2. 24, is a promising therapeutic that has shown efficacy
in ameliorating excessive pigmentation in our previous studies. However, its inherent …